{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:14:06Z","timestamp":1787606046972,"version":"build-2736575974"},"reference-count":47,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T00:00:00Z","timestamp":1146182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>The effect of low\u2010dose aspirin on endoscopic ulcer incidence in cyclo\u2010oxygenase\u20102\u2010selective inhibitor or non\u2010selective non\u2010steroidal anti\u2010inflammatory drug users remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare prospectively the incidence of endoscopic ulcers in healthy subjects receiving low\u2010dose aspirin plus celecoxib or naproxen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this double\u2010blind, placebo\u2010controlled, 1\u2010week study, subjects (50\u201375\u2003years) were randomized to receive aspirin 325\u2003mg o.d. plus either celecoxib 200\u2003mg o.d., naproxen 500\u2003mg b.d., or placebo. Baseline and end of study endoscopies were performed. The primary end point was incidence of one or more gastric and duodenal ulcers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A lower incidence of gastric and duodenal ulcers was seen in celecoxib\/aspirin\u2010treated subjects (19%) vs. naproxen\/aspirin (27%; RR: 0.63, 95% CI: 0.44\u20130.92). Both naproxen\/aspirin and celecoxib\/aspirin groups demonstrated a higher incidence of gastric and duodenal ulcers vs. placebo\/aspirin (8%; RR: 3.7, 95% CI: 1.8\u20137.6 and RR: 2.6, 95% CI: 1.2\u20135.8, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Fewer endoscopic ulcers were observed in patients treated with celecoxib\/aspirin vs. naproxen\/aspirin. However, celecoxib\/aspirin was associated with a significantly higher incidence of gastric and duodenal ulcers than aspirin alone. Further studies are required to determine the generalizability of these findings in the aspirin users and to determine the appropriate strategy to minimize risk in susceptible patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.02912.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T03:45:13Z","timestamp":1146282313000},"page":"1489-1498","source":"Crossref","is-referenced-by-count":40,"title":["The impact of low\u2010dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non\u2010selective non\u2010steroidal anti\u2010inflammatory drug or a cyclo\u2010oxygenase\u20102\u2010selective inhibitor"],"prefix":"10.1111","volume":"23","author":[{"given":"J. L.","family":"GOLDSTEIN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"LOWRY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. L.","family":"LANZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. I.","family":"SCHWARTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. E.","family":"DODGE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7252.13"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.85.3.265"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052717"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21907"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91843-0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90185-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-257"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.14.2093"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36013"},{"key":"e_1_2_6_12_2","first-page":"1429","article-title":"Risk factors and current NSAID use","volume":"26","author":"Simon LS","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110576"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450607"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.234S"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906173402407"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02649.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.115"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02248.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6983.827"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7270.1183"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02194.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70334-3"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16893-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200210000-00011"},{"key":"e_1_2_6_28_2","first-page":"1804","article-title":"Gastroduodenal safety and tolerability of lumiracoxib compared with ibuprofen and celecoxib in patients with osteoarthritis","volume":"31","author":"Hawkey CJ","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_29_2","first-page":"A344","article-title":"Valdecoxib is less ulcerogenic than conventional NSAIDs in osteoarthritis (OA) and rheumatoid arthritis (RA) patients with high risk of peptic ulcer disease","volume":"122","author":"Goldstein J","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_6_30_2","first-page":"A174","article-title":"Influence of H. pylori (Hp) infection and\/or low dose aspirin (ASA) on gastroduodenal ulceration in patients treated with placebo, celecoxib or NSAIDs","volume":"116","author":"Goldstein JL","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1704"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.054"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03740.x"},{"key":"e_1_2_6_34_2","volume-title":"A Comparison of the Effects of SC\u201058635, 100\u2003mg BID, 200\u2003mg BID, Naproxen 500\u2003mg BID and Placebo on the Upper Gastrointestinal Mucosa in Healthy Subjects","author":"Data on File, Protocol N49\u201096\u201002\u2010014","year":"1996"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.11.1243"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050493"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050405"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.001"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012877"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.04.031"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.010"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.08.029"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.14309\/00000434-200509001-00108","article-title":"In low\u2010dose aspirin users: endoscopic gastroduodenal ulcer rates comparing the combination of lansoprazole 30\u2003mg QD and naproxen 500\u2003mg BID vs celecoxib 200\u2003mg QD","volume":"100","author":"Cryer B","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"e_1_2_6_44_2","first-page":"A139","article-title":"Do proton pump inhibitors (PPIs) infer additional gastrointestinal protection in patients given celecoxib? A retrospective cohort study","volume":"128","author":"Rahme E","year":"2005","journal-title":"Gastroenterology"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7504.1366"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000087593.07533.9B"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003199"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70545-7"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.02912.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.02912.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:47:03Z","timestamp":1697212023000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.02912.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,28]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1111\/j.1365-2036.2006.02912.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02912.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,28]]}}}